期刊文献+

动态检测乳腺癌患者手术前后血清IL-6、VEGF-A表达的临床意义 被引量:3

Clinical Consequence for Serum IL-6、VEGF-A Expression to Dynamic Testing Patients Suffered from Galactophore Cancer before Operation
暂未订购
导出
摘要 目的对乳腺癌患者手术前后动态检测血清中白细胞介素-6(IL-6)、血管内皮生长因子-A(VEGF-A),探讨IL-6、VEGF-A表达与乳腺癌预后的相关性。方法作者将60例乳腺癌患者及57例乳腺良性病患者分为两组:观察组(60例乳腺癌患者);对照组(67例乳腺良性病患者)。作者分别手术前、后均采用双抗体夹心法(ELISA法)检测两组病人血清IL-6、VEGF-A的表达。结果①观察组、对照组术前血清IL-6、VEGF-A水平表达具有差异性(P<0.01);术前、后观察组本组血清IL-6、VEGF-A水平表达呈显著差异(P<0.01)。结论通过对两组血清IL-6、VEGF-A表达的动态变化,观察组IL-6、VEGF-A表达的动态变化,显示乳腺癌患者手术前后不同的IL-6、VEGF-A表达与其预后呈正相关性改变。 Objective Dynamic testing serum cell IL-6,VEGF-A for the patients suffered from the galactophore cancer before operation and exploration of the relativity of the expression of IL-6,VEGF-A involved with post-galactophore cancer. Methods The writer divides the patients suffered from the galactophore cancer into two groups,such as 60 cases of galactophore cancers as the observation group (60 eases of observation group) and 57 eases of benign galactophore cancers as (57 cases of comparison group) .The writer uses ELISA method to test two groups of patients totally in the expression of IL-6,VEGF-A before and after the operation;Results (1) the expression of the observation group and comparison group and comparison group have difference( P 〈 0.01) in the serum of IL-6,VEGF- A level before and the expression of the observation group has remarkable difference( P 〈 0.01 )in the serum of IL-6,VEGF-A level before and after operation; Conclusion The positive relativity change for the expression of IL-6, VEGF-A and its post-situation to two groups of the patients suffered from the galactophore cancers are shown in the serum before operation through the dynamic change for the expression of IL-6,VEGF-A to two groups of the patients in the serums of IL-6,VEGF-A of the observation group.
出处 《中国实验诊断学》 2007年第8期1016-1017,共2页 Chinese Journal of Laboratory Diagnosis
关键词 乳腺癌 IL-6 VEGF-A galactophore cancers IL-6 VEGF-A
  • 相关文献

参考文献8

  • 1Lang RA Burgess AW.Autocrine growth factors and tumourigenic transformation[J].Immunol Today,1990,11 (7):244.
  • 2Lee JC.Chow NH,Wang ST,et al.Prognostic value of vasuular endothelial growth factor expression in colorectal cancer patients[J].Eur J Cancer,2000,36(6):748.
  • 3Sun Y,Tokushige K,Isono E,et al.Elevated serum interleakin-6 levels in patients with acute hepatitis[J].J Clin Immunology,1992,12:197.
  • 4李增生,张可成,杨辉,王雪梅.白细胞介素-6mRNA在脑肿瘤的表达及其意义[J].中国肿瘤临床,1999,26(3):185-187. 被引量:17
  • 5Machbaur DM.Serumlevels of interleakin-6 in multiple myeloma and other hematological disorder,correlation with disease activity and other prognostic parameter[J].Ann Hematol,1991,62(2-3):54.
  • 6Seguchi T,Yokawa K,Sugao H,et al.IL-6 activity in urine and serum in patients with bladder carcinoma[J].J Urol,1992,148:791.
  • 7丁士刚,林三仁,董秀云,曲恒怡,杨雪玲,黄淑美,刘文静,周丽雅.胃癌患者血管内皮生长因子-A的测定及其临床意义[J].胃肠病学,2004,9(1):27-29. 被引量:5
  • 8Poon RT,Fan ST,Wong J.Clinical implications of circulating angiogenic factors in cancer patients[J].J Clin Oncol 2001,19:1207.

二级参考文献11

  • 1[1]Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun, 1989, 161: 851~858.
  • 2[2]Liehtner RB, Wiedemuth M, Noeske-Jungblut C, Schimacher V. Rapid effects of EGF on cytoskeletal structures and adhesive properties of highly metastatic rat mammary ade nocarcinoma cells. Clin Exp Metastasis, 1993, 11: 113~125.
  • 3[3]Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Sowa M. Prognostic value of vascu lar endothelial growth factor expression in gastric carcinoma. Cancer, 1996, 77: 858~863.
  • 4[4]Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med, 1971, 285:1182~1186.
  • 5[5]Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, Tsuruta K, Taniguchi T, Okamoto A, Mori T, Yoshida M, Ikeda T, Toninaga T. Concentrations of vas cular endothelial growth factor in the sera of normal con- trols and cancer patients. Clin Cancer Res, 1996, 2: 821~ 826.
  • 6[6]Poon RT, Fan ST, Wong J. Clinical implications of circu lating angiogenic factors in cancer patients. J Clin Oncol, 2001, 19: 1207~1225.
  • 7[7]Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y. Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma. Can cer Lett, 2000, 153: 7~12.
  • 8[8]Hyodo I, Doi T, Endo H, Hosokawa Y, Nishikawa Y, Ta nimizu M, Jinno K, Kotani Y. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer. Eur J Cancer, 1998, 34: 2041~2045.
  • 9[9]Karayiannakis AJ, Syrigos KN, Polychronidis A, Zbar A, Kouraklis G, Simopoulos C, Karatzas G. Cireulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery. Ann Surg, 2002, 236: 37~42.
  • 10谭骏,基因工程原理及实验操作技术,1994年,126页

共引文献18

同被引文献22

  • 1王慧铭,夏明,夏道宗,孙炜,潘宏铭,项伟岚.香菇多糖抗肿瘤作用及其机制的研究[J].浙江中西医结合杂志,2006,16(5):291-292. 被引量:39
  • 2郭军鹏,李红,纪影实,张大方,杨世杰.缝裂层孔菌调节荷瘤小鼠免疫功能的实验研究[J].中国实验诊断学,2007,11(4):514-516. 被引量:2
  • 3Ajdzanovi V Z,Sosi-Jurjevi B T,Filipóvi B R,et al.Genistein affects the morphology of pituitary ACTH cells and decreases circulating levels of ACTH and corticosterone in middle-aged male rats[J].Biol Res,2009,42(1):13-23.
  • 4Benoit I,Drui D,Chaillous L,et al.A corticotroph pituitary adenoma as the initial presentation of familial glucocorticoid deficiency[J].Eur J Endocrinol,2009,161(1):195-199.
  • 5John C D,Buckingham J C.Cytokines:regulation of the hypothalamo-pituitary-adrenocortical axis[J].Curr Opin Pharmacol,2003,3(1):78-84.
  • 6Black V H,Russo J J.Stereological analysis of the guinea pig adrenal:effects of dexamethasone and ACTH treatment with emphasis on the inner cortex.Am J Anat,1980,159(1):85-120.
  • 7Mekhail T,Wood L,Bukowski R.Interleukin-2 in cancer therapy:uses and optimum management of adverse effects[J].BioDrugs.2000,14(5):299.
  • 8Wasser SP.Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides[J].Appl Microbiol Biotechnol.2002,60(3):258.
  • 9Ooi VE,Liu F.Immnunomodulation and anti-cancer activity of polysacharide protein complexes[J].Curr Med Chem,2000,7(7):715.
  • 10Kupfahl C,Geginat G,Hof H.Lentinan has a stimulatory effect on innate and adaptive immunity against murine Listeria monocytogenes infection.Int Immunopharmacol,2006,6(4):686.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部